Prevention of Hepatitis B in Travelers to Endemic Areas
The latest World Health Organization estimate is that there are about 300 million chronic carriers of hepatitis B virus (HBV) worldwide . Prevalence varies from between less than 1% in western Europe and North America, to 10%–20% in Asia and 7%–15% in parts of Africa [2–5]. Non-immune travellers to countries in areas with a high incidence of hepatitis B who reside in low-incidence countries are therefore at an increased risk of contracting an infection.
KeywordsHepatitis Albumin Europe Nigeria Trop
Unable to display preview. Download preview PDF.
- 1.Anonymous (1988) Viral hepatitis. Weekly Epidemiol Rec 63:89–91Google Scholar
- 5.Gesemann M, Amazigo U, Marcus I, Dupasquier I, Staugard F, Scheiermann N (1987) Prevalence of hepatitis B virus markers and Delta antibodies in Nigeria and Botswana. Trop Med Parasitol 38:268–269Google Scholar
- 6.Sansonno DE, Manghisi OG (1987) Auto-antibody to human albumin after vaccination for hepatitis B infection. Ital J Gastroenterol 19:182–183Google Scholar